INFANRIX-IPV SUSPENSION INYECTABLE EN JERINGA PRECARGADA

Glaxosmithkline S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: a96955c87ce64033
Drug Cima Aemps Name: INFANRIX-IPV SUSPENSION INYECTABLE EN JERINGA PRECARGADA
Register Number: 85671
Holder Company Name: Glaxosmithkline S.A.
Marketing Company Name: Glaxosmithkline S.A.
Holder Company Detail Path: /organization/glaxosmithkline-sa
Marketing Company Detail Path: /organization/glaxosmithkline-sa
Authorization Date: 2020-12-29
Dosage Form: SUSPENSIÓN INYECTABLE EN JERINGA PRECARGADA
Dose: 0,5 ml
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glaxosmithkline S.A.
Company Detail Path: /organization/glaxosmithkline-sa

TOXOIDE DIFTERICO

30 UI

TOXOIDE TETANICO

40 UI

BORDETELLA PERTUSSIS TOXOIDE

25 µg

BORDETELLA PERTUSSIS HEMAGLUTININA FILAMENTOSA

25 µg

BORDETELLA PERTUSSIS PERTACTINA

8 µg

POLIOVIRUS INACTIVADO TIPO 1 (MAHONEY) PRODUCIDO EN CELULAS VERO

40 U.D. (UNIDADES ANTIGENICAS D)

POLIOVIRUS INACTIVADO TIPO 2 (MEF-1) PRODUCIDO EN CELULAS VERO

8 U.D. (UNIDADES ANTIGENICAS D)

POLIOVIRUS INACTIVADO TIPO 3 (SAUKETT PRODUCIDO EN CELULAS VERO

32 U.D. (UNIDADES ANTIGENICAS D)

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 29, 2020

Approval ID

a96955c87ce64033

Type

Standard